Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04989283
Title Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer
Recruitment Suspended
Gender
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

lung non-small cell carcinoma

Therapies

Carboplatin

Atezolizumab + Cisplatin

Atezolizumab + Paclitaxel

Atezolizumab + Etoposide

Cisplatin

Etoposide

Paclitaxel

Atezolizumab + Carboplatin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.